ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,493,201, issued on Dec. 9, was assigned to Essilor International (Charenton-le-Pont, France).
"Electro-active ophthalmic device satisfying a prescription for 5 power correction(s), manufacturing method and use of a semi-finished hybrid lens" was invented by Mathieu Meynen (Charenton le Pont, France), Sira Uhalte Nogues (Charenton-le-Pont, France), Antoine Monvoisin (Charenton le Pont, France) and Chafik Habassi (Ormesson-sur-Marne, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "An ophthalmic device satisfying a prescription for at least one power correction for a wearer, a method for manufacturing the ophthalmic device, and a method for applying a...